ログイン

Lipids.
67問 • 1年前
  • Quinn Karylle Fuentes
  • 通報

    問題一覧

  • 1

    Organic compounds found in living organisms.

    Lipids.

  • 2

    Limited solubility in water but dissolve freely in organic solvent.

    Lipids.

  • 3

    Do not have common structural features that serves as basis for defining such compound.

    Lipids.

  • 4

    Classification based in solubility not on any functional groups

    Lipids.

  • 5

    Energy storage..

    Triacylglycerol

  • 6

    Membrane lipids.

    Phospholipid, Sphingoglycolipids, cholesterol.

  • 7

    Emulsification lipids.

    Bile acid.

  • 8

    Has a carboxyl group at the polar end and a hydrocarbon chain at the nonpolar tail

    Amphipatic compound.

  • 9

    Fatty acids are rarely found free in nature but they form part of many commonly occuring lipids.

    Linoleic acid.

  • 10

    Carboxylic acid with linear carbon chain naturally occurring mono carboxylic acid. (True/False)

    True.

  • 11

    C12-C26

    Long chain.

  • 12

    C8-C10

    Medium chain.

  • 13

    C4-C6

    Short chain.

  • 14

    What are the two types of fatty acids.

    Saturated and unsaturated.

  • 15

    What are the two types of unsaturated.

    Monounsaturated and Polyunsaturated.

  • 16

    Chemical messengers

    steroids hormones and eicosanoids.

  • 17

    Numbering starts from the end of carboxyl group If there are only single bonds.

    Saturated fatty acids.

  • 18

    Numbering starts from the end of carboxyl group If there are C-C double bond in the chain.

    unsaturated fatty acids.

  • 19

    In saturated fatty acid the stereochemical at the single binf is usually cis rather than trans. (T/F)

    False

  • 20

    Do not usually have conjugate double bind systems.

    Unsaturated fatty acid.

  • 21

    Fatty acid with two or more C-C double bond.

    Polyunsaturated fatty acid

  • 22

    End most C-C double bond is 3 carbon away from uts methyl end.

    Omega 3.

  • 23

    End most C-C double bond is 6 carbon away from its methyl end.

    Omega 6.

  • 24

    Serve as starting material for the production of several nutritionally impy longer chain omega -6 and omega 3 fatty acid.

    Polyunsaturated fatty acids.

  • 25

    Short chain fatty acid are sparingly soluble. (T/F)

    True.

  • 26

    Long chain fatty acid are water insoluble. (t/f)

    True.

  • 27

    Length of carbon chain degree of unsaturation

    Melting point.

  • 28

    in space filling molecules the number of bend in a FA chain increase the number of double bond increase.( t /f)

    True.

  • 29

    Im energy storage lipid what is the notable exceptional cells?

    Nerve cells and human cells.

  • 30

    What is the most widespread energy storage. material

    Carbohydrates glycogen.

  • 31

    Present in small amounts.

    Energy storage lipids.

  • 32

    Triacylglycerol are concentrated primarily in special cells called?

    Adipocytes.

  • 33

    A simple compound that contain three hyroxyl group.

    Glycerol.

  • 34

    What will happen if all the three alcohol group from ester linkage in fatty acids, what will be the results form?

    Triacylglyerol.

  • 35

    What are the two types of triacylglycerol.

    Simple and mixed triacylglycerol.

  • 36

    Has a 3 identical fatty acid that are esterified and the naturally occurring this type of triacylglycerol are rare.

    Simple triacylglycerol.

  • 37

    The triester form the simple esterification of glycerol with more than one kind of fatty acid

    Mixed triacylglycerol.

  • 38

    Predominantly saturated.

    Fats.

  • 39

    Solid/ Semi solid in room temp

    Fats.

  • 40

    Animal source and tastless.

    Fats.

  • 41

    Predominantly unsaturated.

    Oils.

  • 42

    Liquid at room temp

    Oils.

  • 43

    Plants and fish oil are the source.

    Oil.

  • 44

    Dietary consideration in Mono unsaturated fat.

    15%

  • 45

    Dietary consideration in polyunsaturated fat.

    10%

  • 46

    Dietary consideration in saturated fat.

    <10%

  • 47

    Bad fats.

    Saturated fats.

  • 48

    What fatty acid consider as good fats.

    Monounsaturated fats.

  • 49

    Trans-monounsaturated fats also consider as bad fats.(t/f)

    True.

  • 50

    A fats that can be both "good fats" and "bad fats"

    Polyunsaturated fats.

  • 51

    What omega are important in good fats.

    Omega 3&6.

  • 52

    what are the composition of Nuts

    Fatty acids and Fat.

  • 53

    Base in study eating nuts have a sting protective effect in what disease?

    Coronary heart diease.

  • 54

    nuts also contain valuable antioxidant, vitamin, mineral and plant viber protection. (T/F)

    True.

  • 55

    When an organism uses fatty acids, the ester linkage of triacylglycerol are hydrolyzed by emzyme called?

    Lipase.

  • 56

    When a base such as sodium hydroxide or potassium hydroxide the product reaction of glycerol are?

    Potassium salt.

  • 57

    Hydrolysis in basic solution produce salt for fatty acid and glycerol.

    Saponification.

  • 58

    Peanut oil + H2 will produce

    Peanut butter.

  • 59

    Vegetable oil + H2 will produce.

    Margarine.

  • 60

    Addition if hydrogen across double bond inc degree of saturation.

    Hydrogenation.

  • 61

    Double bond in triacylglycerol are subject to oxidation with O2 In air leads to breakage to C-C

    Oxidation.

  • 62

    Oxidation id alkenes may result into two short chain molecules such as

    Rcoh and Rcooh.

  • 63

    Aldehyde and carboxylic acid so produced often have objectionable odors.

    Oxidation.

  • 64

    Secret mineralocorticoid.

    Zona glumerulosa.

  • 65

    Second outer layer.

    Zona fasiculada.

  • 66

    Inner layer

    Zona Reticularis.

  • 67

    Form adrenal gland above the kidney

    Adrenocorticoids.

  • Cell structure.

    Cell structure.

    Quinn Karylle Fuentes · 28問 · 2年前

    Cell structure.

    Cell structure.

    28問 • 2年前
    Quinn Karylle Fuentes

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    Quinn Karylle Fuentes · 29問 · 2年前

    Electrolytes and non electrolytes

    Electrolytes and non electrolytes

    29問 • 2年前
    Quinn Karylle Fuentes

    MW

    MW

    Quinn Karylle Fuentes · 45問 · 2年前

    MW

    MW

    45問 • 2年前
    Quinn Karylle Fuentes

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    Quinn Karylle Fuentes · 38問 · 2年前

    POST LAB (EXP 4)

    POST LAB (EXP 4)

    38問 • 2年前
    Quinn Karylle Fuentes

    Density and specific gravity

    Density and specific gravity

    Quinn Karylle Fuentes · 34問 · 2年前

    Density and specific gravity

    Density and specific gravity

    34問 • 2年前
    Quinn Karylle Fuentes

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    Quinn Karylle Fuentes · 18問 · 2年前

    FORCES OF ATTRACTION

    FORCES OF ATTRACTION

    18問 • 2年前
    Quinn Karylle Fuentes

    Microbial growth

    Microbial growth

    Quinn Karylle Fuentes · 63問 · 2年前

    Microbial growth

    Microbial growth

    63問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 61問 · 2年前

    Introduction.

    Introduction.

    61問 • 2年前
    Quinn Karylle Fuentes

    Microbial control.

    Microbial control.

    Quinn Karylle Fuentes · 97問 · 2年前

    Microbial control.

    Microbial control.

    97問 • 2年前
    Quinn Karylle Fuentes

    States of matter

    States of matter

    Quinn Karylle Fuentes · 100問 · 2年前

    States of matter

    States of matter

    100問 • 2年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 86問 · 2年前

    Introduction.

    Introduction.

    86問 • 2年前
    Quinn Karylle Fuentes

    Drug development.

    Drug development.

    Quinn Karylle Fuentes · 77問 · 2年前

    Drug development.

    Drug development.

    77問 • 2年前
    Quinn Karylle Fuentes

    CGMP

    CGMP

    Quinn Karylle Fuentes · 9問 · 2年前

    CGMP

    CGMP

    9問 • 2年前
    Quinn Karylle Fuentes

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    Quinn Karylle Fuentes · 24問 · 2年前

    Pharmaceutical ingredients.

    Pharmaceutical ingredients.

    24問 • 2年前
    Quinn Karylle Fuentes

    Powdered & granules

    Powdered & granules

    Quinn Karylle Fuentes · 43問 · 2年前

    Powdered & granules

    Powdered & granules

    43問 • 2年前
    Quinn Karylle Fuentes

    Capsule.

    Capsule.

    Quinn Karylle Fuentes · 24問 · 2年前

    Capsule.

    Capsule.

    24問 • 2年前
    Quinn Karylle Fuentes

    Tablets.

    Tablets.

    Quinn Karylle Fuentes · 23問 · 2年前

    Tablets.

    Tablets.

    23問 • 2年前
    Quinn Karylle Fuentes

    Calculatiom of dose

    Calculatiom of dose

    Quinn Karylle Fuentes · 66問 · 2年前

    Calculatiom of dose

    Calculatiom of dose

    66問 • 2年前
    Quinn Karylle Fuentes

    Postlab 5&6

    Postlab 5&6

    Quinn Karylle Fuentes · 29問 · 2年前

    Postlab 5&6

    Postlab 5&6

    29問 • 2年前
    Quinn Karylle Fuentes

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    Quinn Karylle Fuentes · 33問 · 2年前

    COLLIGATIVE PROPERTIES.

    COLLIGATIVE PROPERTIES.

    33問 • 2年前
    Quinn Karylle Fuentes

    SEMI SOLID

    SEMI SOLID

    Quinn Karylle Fuentes · 69問 · 2年前

    SEMI SOLID

    SEMI SOLID

    69問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology

    Basic immunology

    Quinn Karylle Fuentes · 60問 · 2年前

    Basic immunology

    Basic immunology

    60問 • 2年前
    Quinn Karylle Fuentes

    Basic immunology (2)

    Basic immunology (2)

    Quinn Karylle Fuentes · 62問 · 2年前

    Basic immunology (2)

    Basic immunology (2)

    62問 • 2年前
    Quinn Karylle Fuentes

    Transdermal

    Transdermal

    Quinn Karylle Fuentes · 44問 · 2年前

    Transdermal

    Transdermal

    44問 • 2年前
    Quinn Karylle Fuentes

    Distribution.

    Distribution.

    Quinn Karylle Fuentes · 43問 · 2年前

    Distribution.

    Distribution.

    43問 • 2年前
    Quinn Karylle Fuentes

    Infectious disease.

    Infectious disease.

    Quinn Karylle Fuentes · 65問 · 2年前

    Infectious disease.

    Infectious disease.

    65問 • 2年前
    Quinn Karylle Fuentes

    Infectious diseases (2)

    Infectious diseases (2)

    Quinn Karylle Fuentes · 79問 · 2年前

    Infectious diseases (2)

    Infectious diseases (2)

    79問 • 2年前
    Quinn Karylle Fuentes

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    Quinn Karylle Fuentes · 35問 · 2年前

    Gram positive ( Bacteriology)

    Gram positive ( Bacteriology)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    Quinn Karylle Fuentes · 35問 · 2年前

    All topic. ( Compressed.)

    All topic. ( Compressed.)

    35問 • 2年前
    Quinn Karylle Fuentes

    All topic ( Compressed)

    All topic ( Compressed)

    Quinn Karylle Fuentes · 30問 · 2年前

    All topic ( Compressed)

    All topic ( Compressed)

    30問 • 2年前
    Quinn Karylle Fuentes

    All topics (compressed)

    All topics (compressed)

    Quinn Karylle Fuentes · 13問 · 2年前

    All topics (compressed)

    All topics (compressed)

    13問 • 2年前
    Quinn Karylle Fuentes

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    Quinn Karylle Fuentes · 28問 · 2年前

    Exercise 6 ; Isotonic solution.

    Exercise 6 ; Isotonic solution.

    28問 • 2年前
    Quinn Karylle Fuentes

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    Quinn Karylle Fuentes · 16問 · 2年前

    Exercise 5 : Buffers.

    Exercise 5 : Buffers.

    16問 • 2年前
    Quinn Karylle Fuentes

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    Quinn Karylle Fuentes · 26問 · 2年前

    Exercise 7 : Factors affecting solubility.

    Exercise 7 : Factors affecting solubility.

    26問 • 2年前
    Quinn Karylle Fuentes

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    Quinn Karylle Fuentes · 23問 · 2年前

    Experiment 8: Disintegration.

    Experiment 8: Disintegration.

    23問 • 2年前
    Quinn Karylle Fuentes

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Quinn Karylle Fuentes · 35問 · 2年前

    Experiment 9 ; Interfacial phenomenon and surface tension.

    Experiment 9 ; Interfacial phenomenon and surface tension.

    35問 • 2年前
    Quinn Karylle Fuentes

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 9 : Aromatic ammonia spirit.

    EXP 9 : Aromatic ammonia spirit.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    Quinn Karylle Fuentes · 34問 · 2年前

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

    34問 • 2年前
    Quinn Karylle Fuentes

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    Quinn Karylle Fuentes · 20問 · 2年前

    EXP 12: ACACIA MUCILAGE

    EXP 12: ACACIA MUCILAGE

    20問 • 2年前
    Quinn Karylle Fuentes

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    Quinn Karylle Fuentes · 33問 · 2年前

    EXP13&14 : Starch and Barrium sulfate.

    EXP13&14 : Starch and Barrium sulfate.

    33問 • 2年前
    Quinn Karylle Fuentes

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    Quinn Karylle Fuentes · 37問 · 2年前

    EXP 15 : Liquid petroleum emulsion 1.0

    EXP 15 : Liquid petroleum emulsion 1.0

    37問 • 2年前
    Quinn Karylle Fuentes

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    Quinn Karylle Fuentes · 23問 · 2年前

    EXP 15: Liquid petroleum emulsion 1.1

    EXP 15: Liquid petroleum emulsion 1.1

    23問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae

    Enterobacteriaceae

    Quinn Karylle Fuentes · 35問 · 2年前

    Enterobacteriaceae

    Enterobacteriaceae

    35問 • 2年前
    Quinn Karylle Fuentes

    Enterobacteriaceae.

    Enterobacteriaceae.

    Quinn Karylle Fuentes · 28問 · 2年前

    Enterobacteriaceae.

    Enterobacteriaceae.

    28問 • 2年前
    Quinn Karylle Fuentes

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    Quinn Karylle Fuentes · 31問 · 2年前

    LIQUID DOSAGE FORM 1.0

    LIQUID DOSAGE FORM 1.0

    31問 • 2年前
    Quinn Karylle Fuentes

    Liquid dosage form

    Liquid dosage form

    Quinn Karylle Fuentes · 12問 · 2年前

    Liquid dosage form

    Liquid dosage form

    12問 • 2年前
    Quinn Karylle Fuentes

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    Quinn Karylle Fuentes · 44問 · 2年前

    MICROMERITICS 1.0

    MICROMERITICS 1.0

    44問 • 2年前
    Quinn Karylle Fuentes

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    Quinn Karylle Fuentes · 22問 · 2年前

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

    22問 • 2年前
    Quinn Karylle Fuentes

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    Quinn Karylle Fuentes · 40問 · 2年前

    EXP 8 : KIRBY-BAUER TECHNIQUE

    EXP 8 : KIRBY-BAUER TECHNIQUE

    40問 • 2年前
    Quinn Karylle Fuentes

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    Quinn Karylle Fuentes · 29問 · 2年前

    EXP 9: STAPHYLOCOCCI

    EXP 9: STAPHYLOCOCCI

    29問 • 2年前
    Quinn Karylle Fuentes

    Drug incompatibilities.

    Drug incompatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug incompatibilities.

    Drug incompatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    Drug compatibilities.

    Drug compatibilities.

    Quinn Karylle Fuentes · 41問 · 2年前

    Drug compatibilities.

    Drug compatibilities.

    41問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 35問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    35問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    Quinn Karylle Fuentes · 30問 · 2年前

    BACTERIOLOGY 3

    BACTERIOLOGY 3

    30問 • 2年前
    Quinn Karylle Fuentes

    SUSPENSION.

    SUSPENSION.

    Quinn Karylle Fuentes · 45問 · 2年前

    SUSPENSION.

    SUSPENSION.

    45問 • 2年前
    Quinn Karylle Fuentes

    Colloidal.

    Colloidal.

    Quinn Karylle Fuentes · 40問 · 2年前

    Colloidal.

    Colloidal.

    40問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    Quinn Karylle Fuentes · 38問 · 2年前

    BACTERIOLOGY 4 (Rickettsia)

    BACTERIOLOGY 4 (Rickettsia)

    38問 • 2年前
    Quinn Karylle Fuentes

    BACTERIOLOGY.

    BACTERIOLOGY.

    Quinn Karylle Fuentes · 44問 · 2年前

    BACTERIOLOGY.

    BACTERIOLOGY.

    44問 • 2年前
    Quinn Karylle Fuentes

    Emulsion.

    Emulsion.

    Quinn Karylle Fuentes · 32問 · 2年前

    Emulsion.

    Emulsion.

    32問 • 2年前
    Quinn Karylle Fuentes

    EMULSION

    EMULSION

    Quinn Karylle Fuentes · 42問 · 2年前

    EMULSION

    EMULSION

    42問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    Quinn Karylle Fuentes · 36問 · 2年前

    MEDICAL RELATED PROBLEMS.

    MEDICAL RELATED PROBLEMS.

    36問 • 2年前
    Quinn Karylle Fuentes

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    Quinn Karylle Fuentes · 33問 · 2年前

    MEDICATION RELATED PROBLEMS.

    MEDICATION RELATED PROBLEMS.

    33問 • 2年前
    Quinn Karylle Fuentes

    Mycology.

    Mycology.

    Quinn Karylle Fuentes · 30問 · 2年前

    Mycology.

    Mycology.

    30問 • 2年前
    Quinn Karylle Fuentes

    Mycology 2.0

    Mycology 2.0

    Quinn Karylle Fuentes · 34問 · 2年前

    Mycology 2.0

    Mycology 2.0

    34問 • 2年前
    Quinn Karylle Fuentes

    m

    m

    Quinn Karylle Fuentes · 15問 · 2年前

    m

    m

    15問 • 2年前
    Quinn Karylle Fuentes

    ppr

    ppr

    Quinn Karylle Fuentes · 25問 · 2年前

    ppr

    ppr

    25問 • 2年前
    Quinn Karylle Fuentes

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    Quinn Karylle Fuentes · 20問 · 2年前

    MEDICAL DEVICES.

    MEDICAL DEVICES.

    20問 • 2年前
    Quinn Karylle Fuentes

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    Quinn Karylle Fuentes · 86問 · 1年前

    Pharmacokinetics. (1.0)

    Pharmacokinetics. (1.0)

    86問 • 1年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    Quinn Karylle Fuentes · 100問 · 1年前

    Pharmacokinetics (1.1)

    Pharmacokinetics (1.1)

    100問 • 1年前
    Quinn Karylle Fuentes

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    Quinn Karylle Fuentes · 19問 · 1年前

    Pharmacokinetics (1.2)

    Pharmacokinetics (1.2)

    19問 • 1年前
    Quinn Karylle Fuentes

    Introduction.

    Introduction.

    Quinn Karylle Fuentes · 17問 · 1年前

    Introduction.

    Introduction.

    17問 • 1年前
    Quinn Karylle Fuentes

    Introduction of biochemistry

    Introduction of biochemistry

    Quinn Karylle Fuentes · 76問 · 1年前

    Introduction of biochemistry

    Introduction of biochemistry

    76問 • 1年前
    Quinn Karylle Fuentes

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    Quinn Karylle Fuentes · 56問 · 1年前

    Intro medicanal chemistry.

    Intro medicanal chemistry.

    56問 • 1年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 75問 · 1年前

    Carbohydrates

    Carbohydrates

    75問 • 1年前
    Quinn Karylle Fuentes

    Carbohydrates 1.1

    Carbohydrates 1.1

    Quinn Karylle Fuentes · 31問 · 1年前

    Carbohydrates 1.1

    Carbohydrates 1.1

    31問 • 1年前
    Quinn Karylle Fuentes

    Detect and quality variation.

    Detect and quality variation.

    Quinn Karylle Fuentes · 56問 · 1年前

    Detect and quality variation.

    Detect and quality variation.

    56問 • 1年前
    Quinn Karylle Fuentes

    INTRODUCTION

    INTRODUCTION

    Quinn Karylle Fuentes · 98問 · 1年前

    INTRODUCTION

    INTRODUCTION

    98問 • 1年前
    Quinn Karylle Fuentes

    lab (1-2)

    lab (1-2)

    Quinn Karylle Fuentes · 15問 · 1年前

    lab (1-2)

    lab (1-2)

    15問 • 1年前
    Quinn Karylle Fuentes

    lab 1-2

    lab 1-2

    Quinn Karylle Fuentes · 14問 · 1年前

    lab 1-2

    lab 1-2

    14問 • 1年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    Quinn Karylle Fuentes · 45問 · 1年前

    Pharmaceutical chemistry.

    Pharmaceutical chemistry.

    45問 • 1年前
    Quinn Karylle Fuentes

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    Quinn Karylle Fuentes · 35問 · 1年前

    Pharmaceutical chemistry 1.1

    Pharmaceutical chemistry 1.1

    35問 • 1年前
    Quinn Karylle Fuentes

    Unit 3.

    Unit 3.

    Quinn Karylle Fuentes · 39問 · 1年前

    Unit 3.

    Unit 3.

    39問 • 1年前
    Quinn Karylle Fuentes

    Histamin and kinins

    Histamin and kinins

    Quinn Karylle Fuentes · 70問 · 1年前

    Histamin and kinins

    Histamin and kinins

    70問 • 1年前
    Quinn Karylle Fuentes

    PUD.

    PUD.

    Quinn Karylle Fuentes · 45問 · 1年前

    PUD.

    PUD.

    45問 • 1年前
    Quinn Karylle Fuentes

    ..

    ..

    Quinn Karylle Fuentes · 61問 · 1年前

    ..

    ..

    61問 • 1年前
    Quinn Karylle Fuentes

    lipids.

    lipids.

    Quinn Karylle Fuentes · 71問 · 1年前

    lipids.

    lipids.

    71問 • 1年前
    Quinn Karylle Fuentes

    LAB ✨

    LAB ✨

    Quinn Karylle Fuentes · 93問 · 1年前

    LAB ✨

    LAB ✨

    93問 • 1年前
    Quinn Karylle Fuentes

    Drug discovery.

    Drug discovery.

    Quinn Karylle Fuentes · 87問 · 1年前

    Drug discovery.

    Drug discovery.

    87問 • 1年前
    Quinn Karylle Fuentes

    disease of lipids.

    disease of lipids.

    Quinn Karylle Fuentes · 13問 · 1年前

    disease of lipids.

    disease of lipids.

    13問 • 1年前
    Quinn Karylle Fuentes

    Intro (identify structure)

    Intro (identify structure)

    Quinn Karylle Fuentes · 57問 · 1年前

    Intro (identify structure)

    Intro (identify structure)

    57問 • 1年前
    Quinn Karylle Fuentes

    Carbohydrates

    Carbohydrates

    Quinn Karylle Fuentes · 98問 · 1年前

    Carbohydrates

    Carbohydrates

    98問 • 1年前
    Quinn Karylle Fuentes

    Dynamic.

    Dynamic.

    Quinn Karylle Fuentes · 96問 · 1年前

    Dynamic.

    Dynamic.

    96問 • 1年前
    Quinn Karylle Fuentes

    Unit 1

    Unit 1

    Quinn Karylle Fuentes · 32問 · 1年前

    Unit 1

    Unit 1

    32問 • 1年前
    Quinn Karylle Fuentes

    問題一覧

  • 1

    Organic compounds found in living organisms.

    Lipids.

  • 2

    Limited solubility in water but dissolve freely in organic solvent.

    Lipids.

  • 3

    Do not have common structural features that serves as basis for defining such compound.

    Lipids.

  • 4

    Classification based in solubility not on any functional groups

    Lipids.

  • 5

    Energy storage..

    Triacylglycerol

  • 6

    Membrane lipids.

    Phospholipid, Sphingoglycolipids, cholesterol.

  • 7

    Emulsification lipids.

    Bile acid.

  • 8

    Has a carboxyl group at the polar end and a hydrocarbon chain at the nonpolar tail

    Amphipatic compound.

  • 9

    Fatty acids are rarely found free in nature but they form part of many commonly occuring lipids.

    Linoleic acid.

  • 10

    Carboxylic acid with linear carbon chain naturally occurring mono carboxylic acid. (True/False)

    True.

  • 11

    C12-C26

    Long chain.

  • 12

    C8-C10

    Medium chain.

  • 13

    C4-C6

    Short chain.

  • 14

    What are the two types of fatty acids.

    Saturated and unsaturated.

  • 15

    What are the two types of unsaturated.

    Monounsaturated and Polyunsaturated.

  • 16

    Chemical messengers

    steroids hormones and eicosanoids.

  • 17

    Numbering starts from the end of carboxyl group If there are only single bonds.

    Saturated fatty acids.

  • 18

    Numbering starts from the end of carboxyl group If there are C-C double bond in the chain.

    unsaturated fatty acids.

  • 19

    In saturated fatty acid the stereochemical at the single binf is usually cis rather than trans. (T/F)

    False

  • 20

    Do not usually have conjugate double bind systems.

    Unsaturated fatty acid.

  • 21

    Fatty acid with two or more C-C double bond.

    Polyunsaturated fatty acid

  • 22

    End most C-C double bond is 3 carbon away from uts methyl end.

    Omega 3.

  • 23

    End most C-C double bond is 6 carbon away from its methyl end.

    Omega 6.

  • 24

    Serve as starting material for the production of several nutritionally impy longer chain omega -6 and omega 3 fatty acid.

    Polyunsaturated fatty acids.

  • 25

    Short chain fatty acid are sparingly soluble. (T/F)

    True.

  • 26

    Long chain fatty acid are water insoluble. (t/f)

    True.

  • 27

    Length of carbon chain degree of unsaturation

    Melting point.

  • 28

    in space filling molecules the number of bend in a FA chain increase the number of double bond increase.( t /f)

    True.

  • 29

    Im energy storage lipid what is the notable exceptional cells?

    Nerve cells and human cells.

  • 30

    What is the most widespread energy storage. material

    Carbohydrates glycogen.

  • 31

    Present in small amounts.

    Energy storage lipids.

  • 32

    Triacylglycerol are concentrated primarily in special cells called?

    Adipocytes.

  • 33

    A simple compound that contain three hyroxyl group.

    Glycerol.

  • 34

    What will happen if all the three alcohol group from ester linkage in fatty acids, what will be the results form?

    Triacylglyerol.

  • 35

    What are the two types of triacylglycerol.

    Simple and mixed triacylglycerol.

  • 36

    Has a 3 identical fatty acid that are esterified and the naturally occurring this type of triacylglycerol are rare.

    Simple triacylglycerol.

  • 37

    The triester form the simple esterification of glycerol with more than one kind of fatty acid

    Mixed triacylglycerol.

  • 38

    Predominantly saturated.

    Fats.

  • 39

    Solid/ Semi solid in room temp

    Fats.

  • 40

    Animal source and tastless.

    Fats.

  • 41

    Predominantly unsaturated.

    Oils.

  • 42

    Liquid at room temp

    Oils.

  • 43

    Plants and fish oil are the source.

    Oil.

  • 44

    Dietary consideration in Mono unsaturated fat.

    15%

  • 45

    Dietary consideration in polyunsaturated fat.

    10%

  • 46

    Dietary consideration in saturated fat.

    <10%

  • 47

    Bad fats.

    Saturated fats.

  • 48

    What fatty acid consider as good fats.

    Monounsaturated fats.

  • 49

    Trans-monounsaturated fats also consider as bad fats.(t/f)

    True.

  • 50

    A fats that can be both "good fats" and "bad fats"

    Polyunsaturated fats.

  • 51

    What omega are important in good fats.

    Omega 3&6.

  • 52

    what are the composition of Nuts

    Fatty acids and Fat.

  • 53

    Base in study eating nuts have a sting protective effect in what disease?

    Coronary heart diease.

  • 54

    nuts also contain valuable antioxidant, vitamin, mineral and plant viber protection. (T/F)

    True.

  • 55

    When an organism uses fatty acids, the ester linkage of triacylglycerol are hydrolyzed by emzyme called?

    Lipase.

  • 56

    When a base such as sodium hydroxide or potassium hydroxide the product reaction of glycerol are?

    Potassium salt.

  • 57

    Hydrolysis in basic solution produce salt for fatty acid and glycerol.

    Saponification.

  • 58

    Peanut oil + H2 will produce

    Peanut butter.

  • 59

    Vegetable oil + H2 will produce.

    Margarine.

  • 60

    Addition if hydrogen across double bond inc degree of saturation.

    Hydrogenation.

  • 61

    Double bond in triacylglycerol are subject to oxidation with O2 In air leads to breakage to C-C

    Oxidation.

  • 62

    Oxidation id alkenes may result into two short chain molecules such as

    Rcoh and Rcooh.

  • 63

    Aldehyde and carboxylic acid so produced often have objectionable odors.

    Oxidation.

  • 64

    Secret mineralocorticoid.

    Zona glumerulosa.

  • 65

    Second outer layer.

    Zona fasiculada.

  • 66

    Inner layer

    Zona Reticularis.

  • 67

    Form adrenal gland above the kidney

    Adrenocorticoids.